SCHEMBL2859692

SCHEMBL2859692

CCOC(=O)[C@@H]1CN(Cc2ccccc2)C[C@@H]1CNC(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.48
NPFFR1 Q9GZQ6 1/20 0.43
NPFFR2 Q9Y5X5 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.42
KMT2A Q03164 1/20 0.42
ATM Q13315 1/20 0.41
ALDH1A1 P00352 1/20 0.41
BCHE P06276 3/20 0.41
ACHE P22303 3/20 0.41
SYK P43405 1/20 0.41
DRD2 P14416 4/20 0.41
DRD4 P21917 4/20 0.41
DRD3 P35462 4/20 0.41
SIGMAR1 Q99720 2/20 0.40
CACNA1F O60840 1/20 0.40
CACNA1D Q01668 1/20 0.40
CACNA1S Q13698 1/20 0.40
CACNA1C Q13936 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2866466 0.88 NPFFR1 (0.47) NPFFR1NPFFR2L3MBTL1KMT2AALDH1A1
SCHEMBL2088231 0.88 NPFFR1 (0.47) NPFFR1NPFFR2L3MBTL1KMT2AALDH1A1
SCHEMBL4642395 0.87 NPFFR1 (0.51) NPFFR1NPFFR2L3MBTL1KMT2ADRD2
SCHEMBL4642388 0.87 NPFFR1 (0.51) NPFFR1NPFFR2L3MBTL1KMT2ADRD2
SCHEMBL4640529 0.87 NPFFR1 (0.51) NPFFR1NPFFR2L3MBTL1KMT2ADRD2
SCHEMBL13382580 0.86 NPFFR1 (0.46) NPFFR1NPFFR2L3MBTL1KMT2ADRD2
SCHEMBL4514750 0.82 NPFFR1 (0.47) NPFFR1NPFFR2L3MBTL1KMT2ABCHE
SCHEMBL4520318 0.82 NPFFR1 (0.47) NPFFR1NPFFR2L3MBTL1KMT2ABCHE
SCHEMBL4520311 0.82 NPFFR1 (0.47) NPFFR1NPFFR2L3MBTL1KMT2ABCHE
SCHEMBL4514741 0.82 NPFFR1 (0.47) NPFFR1NPFFR2L3MBTL1KMT2ABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820823-B2 Dual action antibiotics Morphochem Aktiengesellschaft Fur Kominatorische Chemi (DE) 2010-10-26 US disclosed
US-20050096343-A1 Dual action antibiotics MORPHOCHEM AKTIENGESELLSCHAFT FUR KOMBINATORISCHE CHEMIE (DE) 2005-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050096343-A1 Dual action antibiotics SLC11A2, MRPL21, MAP2K5 USP30 2377/4885NPFFR1 2280/4885NPFFR2 2628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.